Top menu

Center of excellence
Stay up to date

Main navigation

Alexander disease
Symptomology
- Pathophysiology
- Burden of disease
Diagnosis
Disease management
Patient profiles
Resources
- Stay up to date

Stay up to date

Sign up to receive the latest news and information on Alexander disease, and to learn about future updates to this website.

Inputs

Name

*Required ﬁeld

Email

Specialty

By clicking this Sign up button, I agree that Ionis and its subsidiaries may use the information I'm submitting to contact me with information about Alexander disease and related therapies. I understand that all personal information I've submitted will be used in accordance with Ionis' privacy policy, and I agree to the Terms of Use. To manage your marketing preferences, go to Your Privacy Choices.

Open references

Kuhn J, Cascella M. Alexander disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 4, 2023.
Li R, Johnson AB, Salomons G, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol. 2005;57(3):310-326. doi:10.1002/ana.20406
Yoshida T, Sasaki M, Yoshida M, et al. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol. 2011;258(11):1998-2008. doi:10.1007/s00415-011-6056-3
Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain. 2008;131(Pt 9):2321-2331. doi:10.1093/brain/awn178
Sosunov A, Olabarria M, Goldman JE. Alexander disease: an astrocytopathy that produces a leukodystrophy. Brain Pathol. 2018;28(3):388-398. doi:10.1111/bpa.12601
Ahmad O, Rowe DB. Adult-onset Alexander’s disease mimicking degenerative disease. Pract Neurol. 2015;15(5):393-395. doi:10.1136/practneurol-2015-001144
Kang YR, Nam TS, Kim JM, et al. Older adult-onset Alexander disease with atypical clinicoradiological features: a case report. Front Neurol. 2023;14:1139047. doi:10.3389/fneur.2023.1139047
Muthusamy K, Sivadasan A, Dixon L, et al. Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions. Front Neurol. 2023;14:1219324. doi:10.3389/fneur.2023.1219324
Vaia Y, Mura E, Tonduti D. Type I Alexander disease: update and validation of the clinical evolution-based classification. Mol Genet Metab. 2023;138(3):107540. doi:10.1016/j.ymgme.2023.107540
Zampini L, Draghi L, Zanchi P. Developmental profiles in children and young adults with Alexander disease. Dev Neurorehabil. 2023;26(4):253-261. doi:10.1080/17518423.2023.2209834
Ruzhnikov MRZ, Brimble E, Hickey RE, Leukodystrophy Care N. Early signs and symptoms of leukodystrophies: A case-based guide. Pediatr Rev. 2021;42(3):133-146. doi:10.1542/pir.2019-0184
Zerem A, Libzon S, Ben Sira L, et al. Utility of genetic testing in children with leukodystrophy. Eur J Paediatr Neurol. 2023;45:29-35. doi:10.1016/j.ejpn.2023.05.008
Parikh S, Bernard G, Leventer RJ, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015;114(4):501-515. doi:10.1016/j.ymgme.2014.12.434
Waldman A, Sollee J, Liu G, Cooper H, Vossough A. Novel classifications of Alexander disease based on MRI phenotypes. Presented at: 2019 Annual Meeting of the American Academy of Neurology; May 4-10, 2019; Philadelphia, PA.
van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol. 2001;22(3):541-552.
Balbi P, Salvini S, Fundaro C, et al. The clinical spectrum of late-onset Alexander disease: a systematic literature review. J Neurol. 2010;257(12):1955-1962. doi:10.1007/s00415-010-5706-1
Adang LA, Sherbini O, Ball L, et al. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Mol Genet Metab. 2017;122(1-2):18-32. doi:10.1016/j.ymgme.2017.08.006
Hagemann TL, Powers B, Lin NH, et al. Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Sci Transl Med. 2021;13(620):eabg4711. doi:10.1126/scitranslmed.abg4711
Clinicaltrials.gov. Bethesda, MD: National Library of Medicine (US). Identifier NCT04849741. A study to evaluate the safety and efficacy of zilganersen (ION373) in patients with Alexander disease (AxD). Accessed April 9, 2025. https://clinicaltrials.gov/study/NCT04849741.
Messing A. Alexander disease. Handb Clin Neurol. 2018;148:693-700. doi:10.1016/B978-0-444-64076-5.00044-2
Barczykowski AL, Foss AH, Duffner PK, Yan L, Carter RL. Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases. Am J Med Genet A. 2012;158A(11):2835-2842. doi:10.1002/ajmg.a.35624
Stellitano LA, Winstone AM, van der Knaap MS, Verity CM. Leukodystrophies and genetic leukoencephalopathies in childhood: a national epidemiological study. Dev Med Child Neurol. 2016;58(7):680-689. doi:10.1111/dmcn.13027
Srivastava S, Waldman A, Naidu S. Alexander Disease. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. November 15, 2002. Updated November 12, 2020.
National Organization for Rare Disorders. Alexander disease. https://rarediseases.org/rare-diseases/alexander-disease/. Accessed June 30, 2023.
Cohen L, Manin A, Medina N, et al. Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: Diagnostic yield in our first 9 years. Ann Hum Genet. 2020;84(1):11-28. doi:10.1111/ahg.12345
Heim P, Claussen M, Hoffmann B, et al. Leukodystrophy incidence in Germany. Am J Med Genet. 1997;71(4):475-478.
Schmidt JL, Pizzino A, Nicholl J, et al. Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing. Am J Med Genet A. 2020;182(8):1906-1912. doi:10.1002/ajmg.a.61641
Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R. The burden of inherited leukodystrophies in children. Neurology. 2010;75(8):718-725. doi:10.1212/WNL.0b013e3181eee46b
Vanderver A, Hussey H, Schmidt JL, Pastor W, Hoffman HJ. Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders. Semin Pediatr Neurol. 2012;19(4):219-223. doi:10.1016/j.spen.2012.10.001
Hagemann TL, Connor JX, Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci. 2006;26(43):11162-11173. doi:10.1523/JNEUROSCI.3260-06.2006
Kiray H, Lindsay SL, Hosseinzadeh S, Barnett SC. The multifaceted role of astrocytes in regulating myelination. Exp Neurol. 2016;283(Pt B):541-549. doi:10.1016/j.expneurol.2016.03.009
Prust M, Wang J, Morizono H, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 2011;77(13):1287-1294. doi:10.1212/WNL.0b013e3182309f72
Joung J, Gallison K, Sollee JJ, et al. Acquisition and loss of developmental milestones and time to disease-related outcomes in cerebral Alexander disease. J Child Neurol. 2023;38(13-14):672-678. doi:10.1177/08830738231210040
van der Knaap MSV, J. Magnetic resonance of myelination and myelin disorders, 3rd ed. American Journal of Neuroradiology. 2006;27(4):947-948.
Arshiany H, Ezzatian B, Artounian V, Alizadeh F, Mohammadian F. Psychiatric onset Alexander disease: an important challenge in neuropsychiatric diagnosis: a case report. Basic Clin Neurosci. 2022;13(2):269-274. doi:10.32598/bcn.2021.1551.1
Anis S, Fay-Karmon T, Lassman S, et al. Adult-onset Alexander disease among patients of Jewish Syrian descent. Neurogenetics. 2023;24(4):303-310. doi:10.1007/s10048-023-00732-w
Bonkowsky JL, Edwards MR, Baker M, et al. Demographics and healthcare use in Alexander disease characterized from US national administrative data. Presented at: United Leukodystrophy Foundation Scientific Symposium; June 27, 2024; Itasca, IL.
Gavazzi F, Adang L, Waldman A, et al. Reliability of the telemedicine application of the Gross Motor Function Measure-88 in patients with leukodystrophy. Pediatr Neurol. 2021;125:34-39. doi:10.1016/j.pediatrneurol.2021.09.012
Lin NH, Jian WS, Snider N, Perng MD. Glial fibrillary acidic protein is pathologically modified in Alexander disease. J Biol Chem. 2024;300(7):107402. doi:10.1016/j.jbc.2024.107402
Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38(6):364-374. doi:10.1016/j.tins.2015.04.003
Siracusa R, Fusco R, Cuzzocrea S. Astrocytes: role and functions in brain pathologies. Front Pharmacol. 2019;10:1114. doi:10.3389/fphar.2019.01114
Hagemann TL, Gaeta SA, Smith MA, Johnson DA, Johnson JA, Messing A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum Mol Genet. 2005;14(16):2443-2458. doi:10.1093/hmg/ddi248
Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet. 2001;27(1):117-120. doi:10.1038/83679
Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE. Alexander disease. J Neurosci. 2012;32(15):5017-23. doi:10.1523/JNEUROSCI.5384-11.2012
Sosunov AA, McKhann GM, 2nd, Goldman JE. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun. 2017;5(1):27. doi:10.1186/s40478-017-0425-9
Yoshida T, Mizuta I, Saito K, et al. Effects of a polymorphism in the GFAP promoter on the age of onset and ambulatory disability in late-onset Alexander disease. J Hum Genet. 2013;58(9):635-638. doi:10.1038/jhg.2013.83
Yazdani PA, St-Jean ML, Matovic S, et al. The experience of parents of children with genetically determined leukoencephalopathies with the health care system: a qualitative study. J Child Neurol. 2023:8830738231176672. doi:10.1177/08830738231176672
Tsuji M, Tanaka M, Tanaka Y, et al. Autopsy report of a woman with infantile Alexander disease who survived 39 years. Neuropediatrics. 2020;51(4):298-301. doi:10.1055/s-0040-1705172
Iwasaki Y, Saito Y, Mori K, et al. An autopsied case of adult-onset bulbospinalform Alexander disease with a novel S393R mutation in the GFAP gene. Clin Neuropathol. 2015;34(4):207-214. doi:10.5414/NP300806
Zaver DB, Douthit NT. A novel mutation in the adult-onset Alexander's disease GFAP gene. Case Rep Med. 2019;2019:2986538. doi:10.1155/2019/2986538
Farina L, Pareyson D, Minati L, et al. Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol. 2008;29(6):1190-1196. doi:10.3174/ajnr.A1060
Namekawa M, Takiyama Y, Honda J, Shimazaki H, Sakoe K, Nakano I. Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature. BMC Neurol. 2010;10:21. doi:10.1186/1471-2377-10-21
Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858-1875. doi:10.1093/brain/awz144
Cai T, Jing S, Li Y, Wu J. A Case Report of Adult-onset Alexander disease with a tumor-like lesion in the lateral ventricle. Case Rep Neurol. 2021;13(2):355-360. doi:10.1159/000516256
Oshima Y, Takahashi-Iwata I, Sato S, Harada T, Yoshida T, Yabe I. Pearls & oy-sters: adult-onset Alexander disease with transient swelling of the medulla oblongata. Neurology. 2021;97(12):602-605. doi:10.1212/WNL.0000000000012268
Ziad F, Cypers G, Phillips M, et al. Adult-onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients. Neuropathol Appl Neurobiol. 2023;49(4):e12927. doi:10.1111/nan.12927
Graff-Radford J, Schwartz K, Gavrilova RH, Lachance DH, Kumar N. Neuroimaging and clinical features in type II (late-onset) Alexander disease. Neurology. 2014;82(1):49-56. doi:10.1212/01.wnl.0000438230.33223.bc
van der Knaap MS, Ramesh V, Schiffmann R, et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology. 2006;66(4):494-498. doi:10.1212/01.wnl.0000198770.80743.37
Yoshida T, Mizuta I, Yasuda R, Mizuno T. Clinical and radiological characteristics of older-adult-onset Alexander disease. Eur J Neurol. 2021;28(11):3760-3767. doi:10.1111/ene.15017
Yoshida T, Mizuta I, Yasuda R, Nakagawa M, Mizuno T. Characteristics of cerebral lesions in adult-onset Alexander disease. Neurol Sci. 2020;41(1):225-227. doi:10.1007/s10072-019-04048-2
Armangue T, Whitehead MT, Tonduti D, et al. Brainstem chipmunk sign: a diagnostic imaging clue across all subtypes of Alexander disease. AJNR Am J Neuroradiol. 2024;45(6):769-772. doi:10.3174/ajnr.A8220
Yoshida T, Mizuta I, Rei Y, et al. Revised guidelines for diagnosing Alexander disease and their validity. J Neurol Sci. 2017;381 (supplement):461-462.
Boronat S, Turon-Viñas E, Mac Manus N, et al. Response to amoxicillin and perampanel in infantile Alexander disease. Epilepsia Open. 2024;9(6):2505-2509. doi: 10.1002/epi4.13077
Keller SR, Mallack EJ, Rubin JP, et al. Practical approaches and knowledge gaps in the care for children with leukodystrophies. J Child Neurol. 2021;36(1):65-78. doi:10.1177/0883073820946154
Van Haren K, Bonkowsky JL, Bernard G, et al. Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab. 2015;114(4):516-526. doi:10.1016/j.ymgme.2014.12.433
Nanetti L, Kearney M, Boesch S, et al. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND). Neurol Sci. 2024;45(3):1007-1016. doi:10.1007/s10072-023-07101-3
Sarkar S, Sinha R, Chakraborty A, Khaitan T, Bhowmik B. Infantile Alexander disease: case report and review of literature. J Clin Diagn Res. 2017;11(6):ZD14–ZD15. doi:10.7860/JCDR/2017/26875.10106
Yuan Y, Wu Q, Huo L, Wang H, Liu X. Case report: Alexander’s disease with ‘head drop’ as the main symptom and literature review. Front Neurol. 2022;13:1002527. doi:10.3389/fneur.2022.1002527
Garcia Ayala ME, Serrano C, Labat E. Young woman with weakness progressing to quadriplegia: Is this multiple sclerosis or something else? A case report (2887). Neurology. 2020;94(15_Supplement). doi:10.1212/WNL.94.15_supplement.2887

Footer

Terms of Use
Privacy Policy
Your Privacy Choices
Contact Us